$1.21
Insights on Zhongchao Inc
Revenue is down for the last 2 quarters, 10.37M → 9.05M (in $), with an average decrease of 12.7% per quarter
Netprofit is down for the last 6 quarters, 4.04M → -6.61M (in $), with an average decrease of 721.7% per quarter
In the last 1 year, Healthequity Inc has given 37.1% return, outperforming this stock by 20.5%
In the last 3 years, Healthequity Inc has given 0.1% return, outperforming this stock by 31.4%
0.0%
Downside
Day's Volatility :3.2%
Upside
3.2%
8.26%
Downside
52 Weeks Volatility :91.46%
Upside
90.69%
Period | Zhongchao Inc | Index (Russel 2000) |
---|---|---|
3 Months | -61.95% | 0.0% |
6 Months | -86.96% | 0.0% |
1 Year | 16.36% | 0.0% |
3 Years | -31.25% | -22.6% |
Market Capitalization | 3.2M |
Book Value | $6.91 |
Earnings Per Share (EPS) | -4.35 |
Profit Margin | -58.33% |
Operating Margin TTM | -9.39% |
Return On Assets TTM | -10.73% |
Return On Equity TTM | -41.83% |
Revenue TTM | 19.4M |
Revenue Per Share TTM | 7.47 |
Quarterly Revenue Growth YOY | 32.1% |
Gross Profit TTM | 9.4M |
EBITDA | -4.9M |
Diluted Eps TTM | -4.35 |
Quarterly Earnings Growth YOY | -0.91 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
FY18 | Y/Y Change | |
---|---|---|
Revenue | 12.9M | ↑ 31.07% |
Net Income | 3.0M | ↑ 97.43% |
Net Profit Margin | 23.47% | ↑ 7.89% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 14.9M | ↑ 15.68% |
Net Income | 4.0M | ↑ 34.03% |
Net Profit Margin | 27.19% | ↑ 3.72% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 18.0M | ↑ 20.88% |
Net Income | 4.5M | ↑ 10.17% |
Net Profit Margin | 24.78% | ↓ 2.41% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 16.3M | ↓ 9.41% |
Net Income | 238.7K | ↓ 94.65% |
Net Profit Margin | 1.46% | ↓ 23.32% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 14.2M | ↓ 13.16% |
Net Income | -2.8M | ↓ 1282.54% |
Net Profit Margin | -19.94% | ↓ 21.4% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 19.4M | ↑ 37.33% |
Net Income | -11.3M | ↑ 301.65% |
Net Profit Margin | -58.33% | ↓ 38.39% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 7.3M | - |
Net Income | 93.5K | - |
Net Profit Margin | 1.28% | - |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 6.9M | ↓ 6.02% |
Net Income | -3.0M | ↓ 3343.86% |
Net Profit Margin | -44.26% | ↓ 45.54% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 10.4M | ↑ 51.34% |
Net Income | -4.7M | ↑ 55.6% |
Net Profit Margin | -45.5% | ↓ 1.24% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 9.1M | ↓ 12.71% |
Net Income | -6.6M | ↑ 40.09% |
Net Profit Margin | -73.02% | ↓ 27.52% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 14.0M | ↑ 101.35% |
Total Liabilities | 2.7M | ↑ 49.62% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 17.7M | ↑ 26.28% |
Total Liabilities | 2.4M | ↓ 9.84% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 34.8M | ↑ 96.28% |
Total Liabilities | 3.0M | ↑ 24.3% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 36.3M | ↑ 4.17% |
Total Liabilities | 3.7M | ↑ 24.11% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 38.6M | ↑ 6.47% |
Total Liabilities | 5.6M | ↑ 51.18% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 24.4M | ↓ 36.77% |
Total Liabilities | 3.4M | ↓ 39.62% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 38.6M | ↓ 0.1% |
Total Liabilities | 5.6M | ↑ 3.92% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 30.5M | ↓ 20.95% |
Total Liabilities | 3.4M | ↓ 40.06% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 30.5M | ↑ 0.0% |
Total Liabilities | 3.4M | ↑ 0.0% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 30.5M | ↑ 0.0% |
Total Liabilities | 3.4M | ↑ 0.0% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 24.4M | ↓ 20.01% |
Total Liabilities | 3.4M | ↑ 0.74% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 24.4M | ↑ 0.0% |
Total Liabilities | 3.4M | ↑ 0.0% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.3M | ↓ 344.14% |
Investing Cash Flow | -504.0K | ↓ 72.54% |
Financing Cash Flow | 4.3M | ↑ 58.74% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.4M | ↑ 7.27% |
Investing Cash Flow | -203.1K | ↓ 59.71% |
Financing Cash Flow | -1.2M | ↓ 127.49% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -1.0M | ↓ 173.71% |
Investing Cash Flow | -4.1M | ↑ 1916.35% |
Financing Cash Flow | 11.5M | ↓ 1064.47% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 2.9M | ↓ 375.75% |
Investing Cash Flow | -4.0M | ↓ 1.89% |
Financing Cash Flow | 0.0 | ↓ 100.0% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -398.3K | ↓ 163.84% |
Investing Cash Flow | -1.6M | ↓ 3777.28% |
Financing Cash Flow | 925.2K | - |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -398.3K | ↑ 0.0% |
Investing Cash Flow | -1.6M | ↑ 0.0% |
Financing Cash Flow | 925.2K | ↑ 0.0% |
Sell
Neutral
Buy
Zhongchao Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Zhongchao Inc | -18.79% | -86.96% | 16.36% | -31.25% | -69.75% |
Solventum Corp | -11.81% | -17.44% | -17.44% | -17.44% | -17.44% |
Veeva Systems Inc. | -15.62% | -4.25% | -11.39% | -40.54% | 10.17% |
Ge Healthcare Technologies Inc. | -3.32% | 11.22% | -4.15% | 27.54% | 27.54% |
Healthequity Inc | 2.46% | 17.61% | 38.04% | 0.15% | 23.92% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Zhongchao Inc | NA | NA | NA | 0.0 | -0.42 | -0.11 | NA | 6.91 |
Solventum Corp | NA | NA | NA | 6.26 | 0.17 | 0.08 | NA | NA |
Veeva Systems Inc. | 51.25 | 51.25 | 1.35 | 4.76 | 0.13 | 0.05 | NA | 28.8 |
Ge Healthcare Technologies Inc. | 22.68 | 22.68 | 20.11 | 4.27 | 0.22 | 0.06 | 0.0 | 16.23 |
Healthequity Inc | 127.63 | 127.63 | 2.29 | 2.19 | 0.03 | 0.03 | NA | 23.63 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Zhongchao Inc | NA | $3.2M | -69.75% | NA | -58.33% |
Solventum Corp | Hold | $10.8B | -17.44% | NA | 15.73% |
Veeva Systems Inc. | Buy | $28.2B | 10.17% | 51.25 | 22.24% |
Ge Healthcare Technologies Inc. | Buy | $35.6B | 27.54% | 22.68 | 8.05% |
Healthequity Inc | Buy | $7.1B | 23.92% | 127.63 | 5.57% |
Susquehanna International Group, LLP
Renaissance Technologies Corp
Organization | Zhongchao Inc |
Employees | 142 |
CEO | Mr. Weiguang Yang |
Industry | Commercial Services |
A Spac I Acquisition Corp
$1.21
-3.19%
Keyarch Acquisition Corp
$1.21
-3.19%
Connexa Sports Technologies Inc
$1.21
-3.19%
Us Value Etf
$1.21
-3.19%
First Wave Biopharma Inc
$1.21
-3.19%
Global X Msci Next Emerging
$1.21
-3.19%
Fat Projects Acquisition Corp
$1.21
-3.19%
Goal Acquisitions Corp
$1.21
-3.19%
Capital Link Global Fintech
$1.21
-3.19%